COMMUNIQUÉS West-GlobeNewswire

Mineralys Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
18/03/2025
RADNOR, Pa., March 18, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD [...]
HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2025 Financial Results
18/03/2025
Highlights of the fiscal year include: Revenue of $1.20 billion, an increase of 20% compared to $999.6 million in FY24. Net income of $96.7 million, an increase of 74% compared to $55.7 million in FY24, with non-GAAP [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/03/2025
SOUTH SAN FRANCISCO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 14, 2025 it granted stock options to purchase an aggregate of 58,631 shares of [...]
BioAegis Therapeutics to Highlight Lead Product Gelsolin’s Critical Role in Immune Function at Upcoming Conferences
18/03/2025
Phase 2 clinical trial will be presented at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) conference in Brussels, Belgium on March 19, 2025. COO Valerie Ceva will present at MedInvest [...]
Antibe Announces Completion of Sale
18/03/2025
TORONTO, March 18, 2025 (GLOBE NEWSWIRE) -- Antibe Therapeutics Inc. (“ Antibe ” or the “ Company ”) announced that, in connection with its previously announced receivership proceedings, the Company completed a [...]
NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update
18/03/2025
EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Guerbet x Intrasense : DUOncoTM Bone : premier algorithme d’IA marqué CE pour la détection automatique des lésions osseuses sur les scanners CT .
18/03/2025
DUOnco TM Bone : premier algorithme d’IA marqué CE pour la détection automatique des lésions osseuses sur les scanners CT La première Intelligence Artificielle marquée CE pour la détection des lésions osseuses Une [...]
DUOncoTM Bone : First CE marked IA algorithm for automatic detection of bone lesions on CT scan.
18/03/2025
DUOnco TM Bone : First CE marked IA algorithm for automatic detection of bone lesions on CT scan The first CE-marked IA for the detection of bones lesions A world premier : an innovate solution expected of the entire [...]
CROSSJECT achieves key ZEPIZURE® manufacturing batch stability milestones
18/03/2025
Press Release CROSSJECT achieves key ZEPIZURE ® manufacturing batch stability milestones Satisfactory 6-month room temperature stability results for the Registration Batch of ZEPIZURE®; CDMO Partner EUROFINS in the [...]
CROSSJECT franchit une étape clé dans la stabilité des lots produits de ZEPIZURE®
18/03/2025
Communiqué de presse CROSSJECT franchit une étape clé dans la stabilité des lots produits de ZEPIZURE® Résultats satisfaisants de stabilité à 6 mois à température ambiante pour le lot d'enregistrement de ZEPIZURE® ; Le [...]
Compass Health Welcomes New Chief Financial Officer, Bringing More Than 20 Years of Experience to Advance Behavioral Healthcare in Northwest Washington
18/03/2025
EVERETT, Wash., March 18, 2025 (GLOBE NEWSWIRE) -- Compass Health, Northwest Washington’s behavioral healthcare leader, recently welcomed Janet Carbary as its new chief financial officer (CFO). With more than 20 years [...]
Lipozem Reviews Consumer Reports Case Study Revealed, Trustworthy Reviews and Complaints, Cover All of its Aspects
18/03/2025
LAKELAND, Fla., March 18, 2025 (GLOBE NEWSWIRE) -- Lipozem is the result of nearly 20 years of research in metabolism, endocrinology, and holistic health by Dr. Julian Ross. Anyone who wants a natural metabolic boost [...]
MATTER 360 Diverts 7.1 Million Pounds of Medical Surplus from Landfills in 2024
18/03/2025
MINNEAPOLIS, March 18, 2025 (GLOBE NEWSWIRE) -- Minnesota-based global NGO MATTER announced today that its MATTER 360 initiative successfully diverted more than 7.1 million pounds of medical surplus from landfills in [...]
TrainHealth Announces FDA Clearance of TrainFES Advanced, Improving Results in Neurological Rehabilitation
18/03/2025
PALO ALTO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- TrainHealth ( www.trainhealth.ai ), a commercial-stage neurological rehabilitation company, seeks to disrupt the neurological rehabilitation market with its new " [...]
Breakthrough T1D Canada calls on the Quebec government to remove age restrictions for insulin pumps
18/03/2025
QUEBEC CITY, March 18, 2025 (GLOBE NEWSWIRE) -- Breakthrough T1D Canada is calling on the Quebec government to adopt the 2022 INESSS recommendation to eliminate current age restrictions on public coverage of insulin [...]
Percée DT1 Canada demande au gouvernement du Québec d'éliminer les restrictions d'âge pour les pompes à insuline
18/03/2025
QUÉBEC, 18 mars 2025 (GLOBE NEWSWIRE) -- Percée DT1 Canada demande au gouvernement du Québec d’adopter la recommandation de l'INESSS de 2022 d’éliminer les restrictions d'âge actuelles pour la couverture publique des [...]
ZHITTYA GENESIS MEDICINE ANNOUNCES: DR. JACK JACOBS, PRESIDENT, TO RECEIVE NEVADABIO HONOR FOR PARKINSON’S DISEASE BREAKTHROUGH
18/03/2025
LAS VEGAS, March 18, 2025 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine proudly announces that Dr. Jack Jacobs , President and Chief Science Officer, will be honored by NevadaBio at its Annual Awards Dinner on Wednesday [...]
Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk
18/03/2025
First US Phase 3 study of Photodynamic Therapy (PDT) to include neck, trunk and extremities Protocol involves one or two PDT treatments using 1-3 tubes of Ameluz ® or vehicle gel over a surface area of up to 240 cm 2 [...]
Iantrek Announces Positive 2-Year Results Demonstrating Efficacy and Safety of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Glaucoma Patients
18/03/2025
White Plains, March 18, 2025 (GLOBE NEWSWIRE) -- Iantrek Announces Positive 2-Year Results Demonstrating Efficacy and Safety of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Glaucoma Patients [...]

Pages